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Lentiviral vectorThe measles virus (MV) glycoproteins hemagglutinin (H) and fusion (F) were recently shown to mediate
transduction of resting lymphocytes by lentiviral vectors. MV vaccine strains use CD46 or signaling
lymphocyte activation molecule (SLAM) as receptor for cell entry. A panel of H protein mutants derived from
vaccine strain or wild-type MVs that lost or gained CD46 or SLAM receptor usage were investigated for their
ability to mediate gene transfer into unstimulated T lymphocytes. The results demonstrate that CD46 is
sufﬁcient for efﬁcient vector particle association with unstimulated lymphocytes. For stable gene transfer into
these cells, however, both MV receptors were found to be essential.y Paul-Ehrlich-Institut, Paul-
103 771255.
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Lentiviral vectors (LVs) are a powerful tool for the genetic
modiﬁcation of human cells for research and therapy. They can be
pseudotyped with glycoproteins from other enveloped viruses. LVs
equipped with the vesicular stomatitis virus glycoprotein (VSV-G)
mediate cell entry into basically all types of human cells with exception
of resting lymphocytes. Recent reports described the exchange of VSV-G
protein against variants of the measles virus (MV) glycoproteins
resulting in cell type speciﬁc gene delivery (Anliker et al., 2010; Funke
et al., 2008, 2009). Moreover, LVs displaying vaccine strain MV
glycoproteins gained the ability to transduce quiescent T and B
lymphocytes without inducing cell cycle progression (Frecha et al.,
2008, 2009).
TheMV glycoproteins, hemagglutinin (H) and fusion (F) protein, are
responsible for receptor attachment andmembrane fusion, respectively.
H protein derived fromMVvaccine strains (Vac) attaches virus particles
to three different receptors, CD46, the signaling lymphocyte activation
molecule (SLAM), and a so far unidentiﬁed receptor on epithelial cells,
thereby activating the F proteinmembrane fusion function (Smith et al.,
2009; Takeda et al., 2007). While vaccine strains can use CD46 or SLAM
as receptor for cell entry into T lymphocytes (Dorig et al., 1993; Naniche
et al., 1993), wild-type (WT) MV uses SLAM only (Erlenhoefer et al.,
2001; Hsu, 2001; Tatsuo et al., 2000). This tropism is retained by LVs
pseudotyped with H and F from vaccine or wild-type strains (Funke
et al., 2009). Here,we investigatedwhichMV receptor is critical for gene
transfer into resting T lymphocytes.A series of ﬁve H protein variants exhibiting different receptor usage
was generated by introducing mutations into H expression plasmids
pCG-HVacΔ18 and pCG-HWTΔ18 (Funke et al., 2009). Mutation I194A
was inserted into the vaccine strain derived H (HVac) to ablate SLAM
receptor usage. While many other SLAM ablating mutations have been
described (Masse et al., 2004; Vongpunsawad et al., 2004), I194A
prevents not only entry via SLAM but also binding to the receptor
(Navaratnarajah et al., 2008). CD46 receptor usage of HVac was
destroyed by mutations Y481A, S548L, and F549S (Nakamura et al.,
2005). Substitutions N390I, N416D, N481Y, and E492Gwere inserted to
gain CD46 usage in wild-type derived H (HWT) (Tahara et al., 2007).
Fig. 1A provides an overview of the modiﬁed H proteins generated in
this study. HVac protein variants were generated by QuikChange site-
directed mutagenesis (Stratagene). The HWT-CD46+ coding region was
synthesized (Geneart) and cloned via PacI/SpeI digestion into pCG-
HWTΔ18. The integrity of all clones was conﬁrmed by sequencing.
LV particles transferring the reporter gene encoding green
ﬂuorescent protein (GFP) were then generated by transient transfection
of HEK-293T cells with the packaging plasmid pCMVΔR8.9, the transfer
vector plasmid pSEW, the F protein expression plasmid pCG-FΔ30, and
an H variant encoding plasmid using polyethyleneimine (Anliker et al.,
2010). For optimal titers, plasmid ratios (HVac:F, 1:7, and HWT:F, 3:5) as
described previously were applied (Funke et al., 2008, 2009). Vector
particleswere centrifuged through a20% sucrose cushion (100,000g, 3 h,
4 °C) and pellets were harvested. Titers of all stockswere determined on
Raji cellswhich express both CD46and SLAM.All vectors reached similar
titers in the range of 4×107 to 2×108 transducing units per milliliter
(data not shown). Next, we determined the vector tropism on CHO-
SLAM cells, only expressing SLAM, andH1080 cells, naturally expressing
Fig. 1.H protein variants and vector tropism. (A) Schematic drawing of H protein mutants used for pseudotyping of LVs. The respective amino acid substitutions in the ectodomain of
HVac (blue) and HWT (green) are shown. (B) Transduction of CHO-SLAM and H1080 cells by the indicated vector particles. Approximately 5×104 cells were seeded into a single well
of a 48-well plate one day before transduction, and then cells were transduced at a multiplicity of infection (MOI) of 5 and 2 days after transduction GFP gene expression was
detected by ﬂuorescent microscopy. Scale bar, 100 μm.
Fig. 2. CD46 is sufﬁcient for vector particle association with unstimulated lymphocytes.
Unstimulated PBMC were incubated with the indicated vector particles harboring a
GFP-labeled HIV-1 matrix protein (MA-GFP) at an MOI of 2 for 6 h at 37 °C. The
percentage of GFP-ﬂuorescent cells (white columns) as well as the mean ﬂuorescence
intensity (MFI; black columns) was determined by FACS analysis. Cells incubated with
cell culture medium alone served as control. Mean values of three independent
experiments with standard deviation (sd) are shown. n.a. indicates not applicable.
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but lost the ability to enter into CHO-SLAM cells (Fig. 1B). In contrast,
almost no GFP expression was detected in H1080 cells transduced with
MVVac-CD46−-LV, while a strong signal was detected in CHO-SLAM cells.
MV pseudotypes displaying HWT-CD46+ proteins transduced both cell
types, demonstrating that, like MVVac-LV, these particles had gained
CD46 receptorusage inaddition to SLAM(Fig. 1B). As expected,MVWT-LV
only transduced CHO-SLAM cells. Thus, all vector types exhibited the
expected host-range properties.
Next, we analyzed the different vector particles for their ability to
associate with unstimulated primary human peripheral blood mono-
nuclear cells (PBMC). For this purpose, vector particles with a GFP-
labeled HIV-1 matrix protein (MA-GFP) using the packaging constructs
pCMVdR8.9 and pCHIVeGFP encoding MA-GFP (Lampe et al., 2007)
were generated. Theseparticleswere equippedwith thepS-CD34-TK-W
transfer vector instead of pSEW, which allowed to distinguish between
the structural protein MA-GFP and expression of the transfer vector by
FACS analysis (CD34 expression on the surface of transduced Raji cells)
to quantify infectivity of the particles as described previously (Funke
et al., 2008). FACS analysis of unstimulated PBMC incubated with the
vector particles revealed considerable differences between the vector
types. All vectors able to enter via CD46 resulted in 2- to 3-fold more
GFP-positive and thus particle-associated cells than the CD46-deﬁcient
vectors. Similarly, the mean ﬂuorescence intensity, representing the
amount of associated particles per cell, was also 2- to 3-fold higher
(Fig. 2).
To clarify which receptor is necessary for efﬁcient transduction of
resting lymphocytes, unstimulated PBMC were transduced with the
different lentiviral vectors transferring the GFP-gene. VSV-G-LV which
cannot transduce resting lymphocytes was used as negative control.Approximately 1×105 cells per well of a 48-well plate were incubated
by centrifugation at 850g for 1.5 h at 32 °C with the vector particles in
a ﬁnal volume of 300 μl. After incubation at 37 °C for additional 1.5 h,
cells were washed twice with RPMI 1640 medium to remove unbound
vector particles. Then, the cells were cultivated in RPMI 1640 medium
supplemented with 10% fetal calf serum, 2 mM L-glutamine, 0.5%
streptomycin/penicillin, and 25 mM HEPES. Three days after transduc-
tion, the cells were stained with CD3-PECy5 (BD Biosciences), and the
percentage of GFP expression within CD3+ T cells was determined by
Fig. 3. SLAM and CD46 are necessary for stable transduction of unstimulated T cells. (A) Unstimulated PBMCs were transduced by the indicated vector particles at an MOI of 5. Three
days after transduction, the T cell population was identiﬁed via CD3 staining and the percentage of GFP-positive cells within the T cell fraction was analyzed by FACS. One
representative experiment out of three independent experiments is shown. (B) To conﬁrm stable GFP expression, the transduced cells of panel A were expanded for an additional of
three days in presence of anti-CD3 antibody, anti-CD28 antibody, and interleukin-2. Then, GFP expression in CD3+ T cells was determined by FACS analysis. One representative
experiment out of three independent experiments is shown.
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MVVac-LVwith a transduction efﬁciency of 18.7%,MVVac-SLAM−-LV that
only recognizes CD46 as entry receptor was inefﬁcient in transduction
(Fig. 3A). Interestingly, MVVac-CD46−-LV could not transduce resting T
cells at all, which implied that CD46 is critical not only for particle cell
association but also for transduction. This was further conﬁrmed by the
inability ofMVWT-LV to transduce the resting T cells, whichwas not due
to absence of SLAM expression. FACS analysis revealed that, before
transduction, the resting T cells of two donors expressed SLAM to a level
of 42.4% (donor A) and 42.9% (donor B), which is well in line with
previously published data (Frecha et al., 2008). Remarkably, when
MVWT-LV had been modiﬁed to use CD46 as receptor, the vector
particles gained T cell transduction competence (Fig. 3A).
To assess the stability of gene transfer, we continued to culture the
transduced T cells in presence of 1 μg/μl of CD3 antibody, 1 μg/μl of CD28
antibody (BD Biosciences), and 100 IU/ml of hIL-2 (Roche), which
mediatesmitotic activation and allows long-term cultivation (Leisegang
et al., 2010). Six days after transduction, themean ﬂuorescence intensity
of the GFP positive cells had considerably increased (Fig. 3B). Apart from
that, the results were very similar to those obtained before stimulation.
The percentage of GFP-positive cells obtained after transduction with
MVVac-SLAM−-LVorMVVac-CD46−-LVwas in thesame lowrange as that
observed with VSV-G-LV. High transduction rates were obtained with
MVVac-LV andMVWT-CD46+-LV.When this experimentwas repeated at
higher (20) and lower (1) MOI, overall similar results were obtained
(datanot shown).At the lowMOI, the level ofGFP-positive cells obtained
with VSV-G-LV dropped below the detection level.
In conclusion, our study demonstrates that both CD46 and SLAM are
essential for stable transduction of unstimulated T cells with measles
virus pseudotyped lentiviral vectors. While a contribution of SLAM as
regulator of lymphocyte signaling (Schwartzberg et al., 2009) was
expected, the requirement for CD46 was rather unexpected. Our data
suggest that CD46 recognition was especially crucial but also sufﬁcient
for the efﬁcient association of vector particles with unstimulated PBMC.
Inefﬁcient binding and fusion has recently been identiﬁed for VSV-G
pseudotyped lentiviral vectors as reason for their failure to transduce
resting T cells (Agosto et al., 2009).
For stable transductionof restingT lymphocytes, efﬁcient association
between vector particles and cells via CD46 was essential but not
sufﬁcient. OnlywhenHprotein variants contactedSLAM in addition,MV
pseudotypes couldmediate efﬁcient gene transfer.While only a fraction
(about 42%) of resting T lymphocytes expresses SLAM, CD46 is
expressed on the whole population (data not shown; Frecha et al.,
2008). It is therefore conceivable that CD46 may serve as primary
attachment receptor on these cells, while SLAM attachment occurs in a
secondstep andmaymodulate cell physiology for vector entry. Thismay
involve remodeling of the actin skeleton as required for productive
entry of HIV-1 into resting lymphocytes (Yoder et al., 2008). For MV, it
has been shown that cell contact of the MV glycoproteins induces
dephosphorylation of coﬁlin and moesin, resulting in actin rearrange-
ment and stablemicrotubule formation (Muller et al., 2006). A potential
role for SLAM may therefore lie in H contact mediated cytoskeleton
rearrangements, which in turn permit transport of vector particles and
reverse transcribed DNA to the nucleus subsequently allowing gene
integration (Buchholz et al., 2009).
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